PDF File
document
May 6, 2014 — 00:00
4336
-
-
PDF File
documentMay 6, 2014 — 00:00 -
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
documentMay 6, 2014 — 00:00 -
PDF File
documentMay 6, 2014 — 00:00 -
SCOR Global Life Embedded Value increases 29% to EUR 4.5 billion in 2013 (EUR 24.10 per share), continuing to provide the Group with significant earnings and strong capital repatriation
documentMay 6, 2014 — 00:00 -
Press ReleasesSCOR Global P&C’s April renewals.
-
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
documentApril 30, 2014 — 00:00 -
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
documentApril 30, 2014 — 00:00 -
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
documentApril 30, 2014 — 00:00 -
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
documentApril 28, 2014 — 00:00 -
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
documentApril 28, 2014 — 00:00 -
The Deepwater Horizon accident has led to a re-evaluation of deepwater drilling procedures.
documentApril 23, 2014 — 00:00
